Severe COVID-19 infection can be a form of viral sepsis with occasionally concomitant bacterial infection.

Continuous renal replacement therapy (CRRT) requires considerable involvement from the bedside nurse.

Cystic fibrosis patient care has advanced greatly in recent years and the mortality rate has improved.

Continuous monitoring on hospital wards can prevent adverse events and unnecessary ICU admissions.

COVID-19 is associated with a high prevalence of coagulopathy and venous thromboembolism.

Procalcitonin testing on admission seems to be a valuable piece of information for early risk assessment and ruling out bacterial co-infection in COVID-19 patients.

The increase in acute kidney injury in COVID-19 patients is resulting in more utilization of renal replacement therapy (RRT) and continuous renal replacement therapy (CRRT).

Alternative strategies are needed to combat and prevent antibiotic-resistant bacterial infections. Host Ashish K. Khanna, MD, FCCP, FCCM, talks with David R. Cameron, PhD, about the potential for bacteriophage prophylaxis in the context of experimental ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.

Review how to best utilize parameters provided by minimally invasive advanced hemodynamic monitors. Host Michael Smith, MD, talks with Michael Scott, MBChB, about clinical thresholds that may warrant continuous advanced hemodynamic monitoring and the application of parameters such as stroke volume and stroke volume variation when administering fluid.

Montefiore Medical Center in the Bronx, New York, USA, quickly converted a children's hospital to an adult COVID-19 hospital.